Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q2 2015 · 10-Q
Revenue$506.10M$506.10M−5.7% vs Q2 2014 Net Income$28.40M$28.40M−10.1% vs Q2 2014 EPS Diluted$0.97$0.97−11.0% vs Q2 2014 Gross Profit$279,600,000−5.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flowderived$38,533,000−49.9% Free Cash Flowderived$6,344,000−86.2% Margins · derivedGross margin55.2%−0.1 pt vs Q2 2014
Operating margin7.9%−0.6 pt vs Q2 2014
Net margin5.6%−0.3 pt vs Q2 2014
ended Jun 30, 2015 · filed Aug 7, 2015 · 38 d after period end